Mihic Tamara, Rainkie Daniel, Wilby Kyle John, Pawluk Shane Ashley
The University of British Columbia, Vancouver, British Columbia, Canada.
Qatar University, Doha, Qatar.
J Evid Based Complementary Altern Med. 2016 Oct;21(4):NP110-26. doi: 10.1177/2156587216658846. Epub 2016 Jul 18.
The clinical effectiveness and value of camel milk as a therapeutic agent is currently unclear. MEDLINE (1946 to March 2016), EMBASE (1974 to March 2016), and Google Scholar were searched using the following terms: milk, bodily secretions, camels, camelus, camelini, camelidae, dromedary, bactrian camel, body fluid, and bodily secretions. Articles identified were reviewed if the study was investigating the use of camel milk for the potential treatment of diseases affecting humans. Of 430 studies, 24 were included after assessment. Identified studies highlighted treatment with camel milk of diseases, including diabetes, autism, cancer, various infections, heavy metal toxicity, colitis, and alcohol-induced toxicity. Although most studies using both the human and animal model do show a clinical benefit with an intervention and camel milk, limitations of these studies must be taken into consideration before widespread use. Based on the evidence, camel milk should not replace standard therapies for any indication in humans.
目前尚不清楚骆驼奶作为一种治疗剂的临床疗效和价值。使用以下检索词在MEDLINE(1946年至2016年3月)、EMBASE(1974年至2016年3月)和谷歌学术上进行了检索:牛奶、身体分泌物、骆驼、骆驼属、骆驼亚科、骆驼科、单峰骆驼、双峰骆驼、体液和身体分泌物。如果研究是在调查骆驼奶用于潜在治疗影响人类疾病的用途,则对检索到的文章进行综述。在430项研究中,评估后纳入了24项。已确定的研究强调了用骆驼奶治疗多种疾病,包括糖尿病、自闭症、癌症、各种感染、重金属中毒、结肠炎和酒精诱导的毒性。尽管大多数使用人类和动物模型的研究确实显示干预骆驼奶有临床益处,但在广泛使用之前必须考虑这些研究的局限性。基于现有证据,骆驼奶不应替代人类任何适应症的标准疗法。